The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the fourth quarter, which unveil their equity positions as of ...
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of ...
The stock price of Fate Therapeutics (FATE) has seen a solid 16% rise over the last five trading days, while it’s up 13% over the last ten trading days, and we believe the rally may continue in the ...
Shares of Fate Therapeutics, Inc. (FATE) were in the spotlight on Monday morning after the company said that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced ...
After a stellar 5x rise since the March 23 levels of last year, at the current price of around $114 per share we believe Fate Therapeutics stock (NASDAQ: FATE), a biopharmaceuticals company focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results